Search Results - "ABRAMS, Julian A"

Refine Results
  1. 1

    Proton pump inhibitors alter the composition of the gut microbiota by Jackson, Matthew A, Goodrich, Julia K, Maxan, Maria-Emanuela, Freedberg, Daniel E, Abrams, Julian A, Poole, Angela C, Sutter, Jessica L, Welter, Daphne, Ley, Ruth E, Bell, Jordana T, Spector, Tim D, Steves, Claire J

    Published in Gut (01-05-2016)
    “…Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and treat GI disorders such as peptic ulcers and gastro-oesophageal reflux…”
    Get more information
    Journal Article
  2. 2

    Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial by Freedberg, Daniel E, Toussaint, Nora C, Chen, Sway P, Ratner, Adam J, Whittier, Susan, Wang, Timothy C, Wang, Harris H, Abrams, Julian A

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2015)
    “…We conducted an open-label crossover trial to test whether proton pump inhibitors (PPIs) affect the gastrointestinal microbiome to facilitate Clostridium…”
    Get full text
    Journal Article
  3. 3

    Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma by Runge, Thomas M., MD, MPH, Abrams, Julian A., MD, MS, Shaheen, Nicholas J., MD, MPH

    Published in Gastroenterology clinics of North America (01-06-2015)
    “…Barrett’s esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC), a disease with increasing burden in the Western world, especially in white men…”
    Get full text
    Journal Article
  4. 4

    Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients by Freedberg, Daniel E, Salmasian, Hojjat, Friedman, Carol, Abrams, Julian A

    Published in The American journal of gastroenterology (01-11-2013)
    “…Observational studies suggest that proton pump inhibitors (PPIs) are a risk factor for incident Clostridium difficile infection (CDI). Data also suggest an…”
    Get full text
    Journal Article
  5. 5

    Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer by Sharaiha, Reem Z., Halazun, Karim J., Mirza, Farooq, Port, Jeffrey L., Lee, Paul C., Neugut, Alfred I., Altorki, Nasser K., Abrams, Julian A.

    Published in Annals of surgical oncology (01-11-2011)
    “…Background The prognosis for patients with esophageal cancer is poor, even among those who undergo potentially curative esophagectomy. The…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis by Horvath, Angela, Rainer, Florian, Bashir, Mina, Leber, Bettina, Schmerboeck, Bianca, Klymiuk, Ingeborg, Groselj-Strele, Andrea, Durdevic, Marija, Freedberg, Daniel E., Abrams, Julian A., Fickert, Peter, Stiegler, Philipp, Stadlbauer, Vanessa

    Published in Scientific reports (19-08-2019)
    “…Proton pump inhibitors (PPI) are an invaluable therapy option for acid related diseases; however, PPI therapy is also linked to a series of side effects in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Rapid gastrointestinal loss of Clostridial Clusters IV and XIVa in the ICU associates with an expansion of gut pathogens by Livanos, Alexandra E, Snider, Erik J, Whittier, Susan, Chong, David H, Wang, Timothy C, Abrams, Julian A, Freedberg, Daniel E

    Published in PloS one (01-08-2018)
    “…Commensal gastrointestinal bacteria resist the expansion of pathogens and are lost during critical illness, facilitating pathogen colonization and infection…”
    Get full text
    Journal Article
  10. 10

    The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome by Freedberg, Daniel E., MD, MS, Lebwohl, Benjamin, MD, MS, Abrams, Julian A., MD, MS

    Published in Clinics in laboratory medicine (01-12-2014)
    “…Potent gastric acid suppression using proton pump inhibitors (PPIs) is common in clinical practice but may have important effects on human health that are…”
    Get full text
    Journal Article
  11. 11

    Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer by Laszkowska, Monika, Truong, Han, Faye, Adam S., Kim, Judith, Tan, Sarah Xinhui, Lim, Francesca, Abrams, Julian A., Hur, Chin

    Published in Digestive diseases and sciences (01-08-2022)
    “…Background and Aims Guidelines cite extensive gastric intestinal metaplasia (GIM) as a bigger risk factor for gastric cancer (GC) than limited GIM and an…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Dating the Rise of Esophageal Adenocarcinoma: Analysis of Connecticut Tumor Registry Data, 1940-2007 by ABRAMS, Julian A, SHARAIHA, Reem Z, GONSALVES, Lou, LIGHTDALE, Charles J, NEUGUT, Alfred I

    “…The timing of onset of the rise in incidence of esophageal adenocarcinoma (EAC) has not been clearly defined, and doing so may provide clues with regard to…”
    Get full text
    Journal Article
  15. 15

    Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19 by Miller, Emily Happy, Annavajhala, Medini K, Chong, Alexander M, Park, Heekuk, Nobel, Yael R, Soroush, Ali, Blackett, John W, Krigel, Anna, Phipps, Meaghan M, Freedberg, Daniel E, Zucker, Jason, Sano, Ellen D, Uhlemann, Anne-Catrin, Abrams, Julian A

    Published in Microbiology spectrum (31-10-2021)
    “…Bacterial-viral interactions in saliva have been associated with morbidity and mortality for respiratory viruses such as influenza and SARS-CoV. However, such…”
    Get full text
    Journal Article
  16. 16

    Racial and Ethnic Disparities in the Prevalence of Barrett’s Esophagus Among Patients Who Undergo Upper Endoscopy by Abrams, Julian A, Fields, Sydney, Lightdale, Charles J, Neugut, Alfred I

    Published in Clinical gastroenterology and hepatology (01-01-2008)
    “…Background & Aims: The incidence of esophageal adenocarcinoma (EAC) in blacks and Hispanics is well-described, but racial differences in the risk of Barrett’s…”
    Get full text
    Journal Article
  17. 17

    Diverging Trends in the Incidence of Reflux-related and Helicobacter pylori-related Gastric Cardia Cancer by Abrams, Julian A, Gonsalves, Lou, Neugut, Alfred I

    Published in Journal of clinical gastroenterology (01-04-2013)
    “…GOALS:To describe historical incidence trends of 2 subtypes of gastric cardia cancer. BACKGROUND:The incidence of gastric cardia cancer has increased in…”
    Get full text
    Journal Article
  18. 18

    Folic Acid Increases Global DNA Methylation and Reduces Inflammation to Prevent Helicobacter-Associated Gastric Cancer in Mice by Gonda, Tamas A, Kim, Young–In, Salas, Martha C, Gamble, Mary V, Shibata, Wataru, Muthupalani, Sureshkumar, Sohn, Kyoung–Jin, Abrams, Julian A, Fox, James G, Wang, Timothy C, Tycko, Benjamin

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-2012)
    “…Background & Aims Previous studies have suggested that dietary folic acid (FA) can protect against certain types of cancers. However, the findings have varied,…”
    Get full text
    Journal Article
  19. 19
  20. 20